Optimizing disease progression assessment using blinded central independent review and comparing it with investigator assessment in the PRIMA/ENGOT-ov26/GOG-3012 trial: challenges and solutions

  1. Herzog, T.J.
  2. Wahab, S.A.
  3. Mirza, M.R.
  4. Pothuri, B.
  5. Vergote, I.
  6. Graybill, W.S.
  7. Malinowska, I.A.
  8. York, W.
  9. Hurteau, J.A.
  10. Gupta, D.
  11. González-Martin, A.
  12. Monk, B.J.
Aldizkaria:
International Journal of Gynecological Cancer

ISSN: 1525-1438,  1048-891X

Argitalpen urtea: 2023

Alea: 33

Zenbakia: 11

Orrialdeak: 1733-1742

Mota: Artikulua

DOI: 10.1136/IJGC-2023-004605 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus